                         SEQUENCE LISTING

<110>  Matthias W. Rath
       RATH, Matthias W
       Niedzwiecki, Aleksandra
       ROOMI, WAHEED M
 
<120>  METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE

<130>  RIPLLC018.003PCT1

<140>  13175937
<141>  2011-07-04

<150>  13012769
<151>  2011-01-24

<160>  21    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  1

Cys Pro Arg Lys Pro Lys Trp Asp Lys Cys 
1               5                   10  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  2

Cys His Phe Pro Phe Ile Phe Glu Gly Arg Ser Tyr Ser Ala Cys 
1               5                   10                  15  


<210>  3
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  3

Asp Thr Asp Asp Arg Phe Gly Phe 
1               5               


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  4

Asp Arg Asp Lys Leu Phe Gly Phe Cys Pro Thr Arg Ala Asp Ser 
1               5                   10                  15  


<210>  5
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide sequence

<400>  5

Asp Lys Asp Gly Lys Phe Gly Phe 
1               5               


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide sequence

<400>  6

Asp Ala Asp Arg Gln Phe Gly Phe 
1               5               


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  7

Asp Thr Asp Arg Lys Tyr Gly Phe 
1               5               


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oilgopeptide Sequence

<400>  8

Asp Lys Asp Lys Ile Phe Gly Phe 
1               5               


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Olgipeptide Sequence

<400>  9

Asp Lys Asp Lys Lys Tyr Gly Phe 
1               5               


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  10

Asp Thr Asp Arg Arg Phe Gly Phe 
1               5               


<210>  11
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Olifopeptide Sequence

<400>  11

Asp Lys Asp Gly Lys Phe Gly Phe 
1               5               


<210>  12
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oilgopeptide Sequence

<400>  12

Cys His Phe Pro Phe Thr Phe Glu Gly Arg Ser Tyr Leu Ser Cys 
1               5                   10                  15  


<210>  13
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide sequence

<400>  13

Cys His Phe Pro Phe Ile Phe Glu Gly Arg Ser Tyr Ser Arg Cys 
1               5                   10                  15  


<210>  14
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequences

<400>  14

Cys His Phe Pro Phe Leu Phe Glu Gly Thr Ser Tyr Ser Ser Cys 
1               5                   10                  15  


<210>  15
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequences

<400>  15

Cys His Phe Pro Phe Arg Phe Gln Asn Lys Pro Tyr Lys His Cys 
1               5                   10                  15  


<210>  16
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequences

<400>  16

Cys His Phe Pro Phe Thr Phe Glu Gly Lys Ser Tyr Thr Ser Cys 
1               5                   10                  15  


<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  17

Asp Gln Asp Lys Leu Tyr Gly Phe Cys Pro Thr Arg Val Asp Ala 
1               5                   10                  15  


<210>  18
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequences

<400>  18

Asp Lys Ala Asp Gly Phe Cys Pro Thr Arg Ala Asp Val Thr Val 
1               5                   10                  15  


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequences

<400>  19

Asp Gln Asp Lys Leu Tyr Gly Phe Cys Pro Thr Arg Val Asp Ala 
1               5                   10                  15  


<210>  20
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  20

Asp Lys Lys Tyr Gly Phe Cys Pro Asn Arg Asp Thr Ala Val Ile 
1               5                   10                  15  


<210>  21
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Oligopeptide Sequence

<400>  21

Asp Lys Asp Lys Leu Tyr Gly Phe Cys Pro Thr Arg Ala Asp Ser 
1               5                   10                  15  


